Condition: Atrial Fibrillation · Sponsor: Biosense Webster, Inc.
The purpose of this study is to demonstrate the safety and 12-month effectiveness of the BWI OMNYPULSE™ pulsed field ablation (PFA) platform for pulmonary vein isolation (PVI) in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF), an irregular heart rate that causes abnormal blood flow.
This description comes directly from the study's public registry record.
Study Contact · 949-789-3919 · rshar120@its.jnj.com
Always discuss trial participation with your own doctor first.
| Phoenix Cardiovascular Research Group | Phoenix, Arizona, United States | Recruiting |
| Mills Peninsula Health Services | Burlingame, California, United States | Recruiting |
| Scripps Clinic/Prebys Cardiovascular Institute | La Jolla, California, United States | Withdrawn |
| Cardiovascular Associates of Marin | Larkspur, California, United States | Recruiting |
| Loma Linda Medical Center | Loma Linda, California, United States | Withdrawn |
| Hoag Memorial Hospital | Newport Beach, California, United States | Recruiting |
| San Diego Cardiac Center | San Diego, California, United States | Recruiting |
| California Pacific Medical Center- Sutter Health | San Francisco, California, United States | Withdrawn |
| Providence Saint John s Health Center | Santa Monica, California, United States | Withdrawn |
| University of Colorado | Aurora, Colorado, United States | Recruiting |
| Hartford Hospital | Hartford, Connecticut, United States | Recruiting |
| Ascension St. Vincent's | Jacksonville, Florida, United States | Recruiting |
+ 34 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06455098